Correlation Between Edgewise Therapeutics and Cybin
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Cybin at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Cybin into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Cybin Inc, you can compare the effects of market volatilities on Edgewise Therapeutics and Cybin and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Cybin. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Cybin.
Diversification Opportunities for Edgewise Therapeutics and Cybin
0.78 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Edgewise and Cybin is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Cybin Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cybin Inc and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Cybin. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cybin Inc has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Cybin go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and Cybin
Given the investment horizon of 90 days Edgewise Therapeutics is expected to generate 1.03 times more return on investment than Cybin. However, Edgewise Therapeutics is 1.03 times more volatile than Cybin Inc. It trades about 0.08 of its potential returns per unit of risk. Cybin Inc is currently generating about 0.0 per unit of risk. If you would invest 917.00 in Edgewise Therapeutics on August 31, 2024 and sell it today you would earn a total of 2,383 from holding Edgewise Therapeutics or generate 259.87% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Edgewise Therapeutics vs. Cybin Inc
Performance |
| Timeline |
| Edgewise Therapeutics |
| Cybin Inc |
Edgewise Therapeutics and Cybin Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Edgewise Therapeutics and Cybin
The main advantage of trading using opposite Edgewise Therapeutics and Cybin positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Cybin can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cybin will offset losses from the drop in Cybin's long position.| Edgewise Therapeutics vs. Cue Biopharma | Edgewise Therapeutics vs. Eliem Therapeutics | Edgewise Therapeutics vs. Inhibrx | Edgewise Therapeutics vs. Molecular Partners AG |
| Cybin vs. Mind Medicine | Cybin vs. Seelos Therapeutics | Cybin vs. GH Research PLC | Cybin vs. Awakn Life Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |